Showing 2 posts of 2 posts found.


India’s National Task Force rejects Biocon’s itolizumab for COVID-19

July 27, 2020
Sales and Marketing Biocon, COVID-19, India, Itolizumab

Biocon was hit with bad news over the weekend as the National Task Force for COVID-19 in its home country …


Itolizumab “significantly reduced mortality” in hospitalised COVID-19 patients with respiratory distress, secures emergency use authorisation in India

July 13, 2020
Research and Development, Sales and Marketing COVID-19, Itolizumab, coronavirus

Itolizumab, a drug currently being developed by biotech firm Equillium for autoimmune and inflammatory disorders, “significantly reduced mortality” in hospitalised …

Latest content